BETA

IPO registrations (S-1, F-1) · Registrants

Dare Bioscience, Inc.

SEC CIK
1401914 · filings on EDGAR ↗
Former names
Cerulean Pharma Inc. (2009–2017); Tempo Pharmaceuticals Inc (2007–2008)
Registration
Form S-1, first filed 2014-03-10, last 2026-08-26; 6 initial registrations, 6 amendments
Outcome
Final prospectus filed 2014-04-14; declared effective 2014-04-10
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
3655 NOBEL DRIVE, SUITE 260, San Diego, CA 92122
EIN
20-4139823
Ticker
DARE (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
Dare Bioscience, Inc. on the corporate pages

Offering terms

Proposed price range
$11.00–$13.00 per share (S-1/A filed 2014-03-31)
Final price
$7.00 per share, below the range (424B4 filed 2014-04-14, an initial public offering)
Shares sold
8,500,000
Gross proceeds
$59,500,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol CERU
Lead underwriters
Leerink Partners (5,100,001 shares)
Syndicate
Canaccord Genuity (1,333,333); JMP Securities (1,333,333); Wedbush Securities (1,333,333)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 28

FiledFormWhat it isName as filedEDGAR
2014-03-10S-1S-1 (registration)Cerulean Pharma Inc.0001193125-14-090300 ↗
2014-03-28S-1/AS-1/A (amendment)Cerulean Pharma Inc.0001193125-14-120764 ↗
2014-03-31S-1/AS-1/A (amendment)Cerulean Pharma Inc.0001193125-14-122758 ↗
2014-04-10EFFECTEFFECT (declared effective)Cerulean Pharma Inc.9999999995-14-000947 ↗
2014-04-14424B4424B4 (final prospectus)Cerulean Pharma Inc.0001193125-14-140851 ↗
2015-03-20S-1S-1 (registration)Cerulean Pharma Inc.0001193125-15-100362 ↗
2015-03-30S-1/AS-1/A (amendment)Cerulean Pharma Inc.0001193125-15-111761 ↗
2015-04-06S-1/AS-1/A (amendment)Cerulean Pharma Inc.0001193125-15-119334 ↗
2015-04-06EFFECTEFFECT (declared effective)Cerulean Pharma Inc.9999999995-15-000801 ↗
2015-04-07424B4424B4 (final prospectus)Cerulean Pharma Inc.0001193125-15-121486 ↗
2015-08-28EFFECTEFFECT (declared effective)Cerulean Pharma Inc.9999999995-15-002404 ↗
2016-10-14EFFECTEFFECT (declared effective)Cerulean Pharma Inc.9999999995-16-005972 ↗
2018-09-21EFFECTEFFECT (declared effective)Dare Bioscience, Inc.9999999995-18-002432 ↗
2018-09-21EFFECTEFFECT (declared effective)Dare Bioscience, Inc.9999999995-18-002433 ↗
2020-05-01S-1S-1 (registration)Dare Bioscience, Inc.0001401914-20-000060 ↗
2020-05-12EFFECTEFFECT (declared effective)Dare Bioscience, Inc.9999999995-20-001128 ↗
2020-06-08EFFECTEFFECT (declared effective)Dare Bioscience, Inc.9999999995-20-001366 ↗
2020-12-22S-1S-1 (registration)Dare Bioscience, Inc.0001401914-20-000133 ↗
2020-12-23S-1/AS-1/A (amendment)Dare Bioscience, Inc.0001401914-20-000136 ↗
2021-01-05S-1/AS-1/A (amendment)Dare Bioscience, Inc.0001401914-21-000010 ↗
2021-01-07EFFECTEFFECT (declared effective)Dare Bioscience, Inc.9999999995-21-000080 ↗
2021-04-07EFFECTEFFECT (declared effective)Dare Bioscience, Inc.9999999995-21-001332 ↗
2024-05-01EFFECTEFFECT (declared effective)Dare Bioscience, Inc.9999999995-24-001309 ↗
2024-05-10EFFECTEFFECT (declared effective)Dare Bioscience, Inc.9999999995-24-001484 ↗
2024-11-15S-1S-1 (registration)Dare Bioscience, Inc.0001493152-24-046346 ↗
2024-11-26EFFECTEFFECT (declared effective)Dare Bioscience, Inc.9999999995-24-003590 ↗
2026-08-26S-1S-1 (registration)Dare Bioscience, Inc.0001493152-26-040265 ↗
2026-09-03EFFECTEFFECT (declared effective)Dare Bioscience, Inc.9999999995-26-002882 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2014-03-31S-1/Aregistration statement$11.00–$13.005,000,000-Nasdaq CERU4primary document; range, shares headline, cover names 4document ↗
2014-04-14424B4final prospectus$7.008,500,000$59,500,000Nasdaq CERU4primary document; price sentence, shares headline, proceeds table, underwriting table 4, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Bessemer Venture Partners VII Institutional L.P.Other; TenPercentOwner22014
Bessemer Venture Partners VII L.P.Other; TenPercentOwner22014
Crane Alan LDirector,TenPercentOwner52014–2016
Crane Family Irrevocable Trust- 2002TenPercentOwner12014
Crane Howard R.TenPercentOwner12014
CVF LLCTenPercentOwner32014–2015
Deer VII & Co. L.P.Other; TenPercentOwner22014
Deer VII & Co. Ltd.Other; TenPercentOwner22014
FETZER OLIVERDirector,Officer; Director,Officer,TenPercentOwnerPresident and CEO42014
FRIEDMAN PAUL ADirector72014–2017
Garmey Edward GraemeOfficerSr. VP, Chief Medical Officer32014–2015person page Fuzzy
GUIFFRE CHRISTOPHERD TDirector,Officer; OfficerChief Executive Officer; Chief Operating Officer; Sr. VP, Chief Business Officer102014–2017
Hall Steven EdwardDirector,TenPercentOwner42014–2016
LILLY ELI & COTenPercentOwner22014
Lilly Ventures Fund I LLCTenPercentOwner22014
Lux Capital Management, LLCOther; TenPercentOwner22014
Lux Venture Associates II, LLCOther; TenPercentOwner22014
Lux Venture Partners II, L.P.TenPercentOwner12014
Lux Ventures II, L.P.Other; TenPercentOwner22014
Lux Ventures II Partners Fund I LLCOther; TenPercentOwner22014
Lux Ventures II Sidecar LPOther; TenPercentOwner22014
MCKEE WILLIAMDirector52014–2017
Polaris Venture Management Co IV LLCTenPercentOwner22014
Polaris Venture Management Co. V, L.L.C.TenPercentOwner22014
POLARIS VENTURE PARTNERS ENTREPRENEURS FUND IV LPTenPercentOwner22014
Polaris Venture Partners Entrepreneurs' Fund V, L.P.TenPercentOwner22014
Polaris Venture Partners Founders' Fund V, L.P.TenPercentOwner22014
POLARIS VENTURE PARTNERS IV LPTenPercentOwner22014
Polaris Venture Partners Special Founders' Fund V, L.P.TenPercentOwner22014
Polaris Venture Partners V, L.P.TenPercentOwner22014
RASTETTER WILLIAM HDirector182014–2026
Roberts Karen LynnOfficerSr VP Finance & Administrat42014–2015
Rock Springs Capital Management LPOther; TenPercentOwner22014
Sasisekharan RamDirector,TenPercentOwner22014–2015
Sengupta ShiladityaTenPercentOwner12014
TEPPER ROBERT IDirector22014–2015
VEF Management V, LLCTenPercentOwner22014
VENROCK ASSOCIATES V LPTenPercentOwner22014
Venrock Entrepreneurs Fund V, L.P.TenPercentOwner22014
Venrock Management V, LLCTenPercentOwner22014
Venrock Partners Management V, LLCTenPercentOwner22014
VENROCK PARTNERS V L PTenPercentOwner22014
Kelley Susan L.Director162014–2026
Parkinson David RossDirector62014–2017
BELOFF GREGGOfficerCFO; Interim CFO42015–2017
Arbuckle Stuart ADirector52015–2017
Carvajal AlejandraOfficerVP, General Counsel52015–2017
WALT DAVID RDirector252015–2017
Senderowicz AdrianOfficerSVP, Chief Medical Officer62015–2017
ONeill James EOfficerPrincipal Accounting Officer52016–2017
Eliasof ScottOfficerSVP, Chief Scientific Officer42016–2017
HAWLEY ROGERDirector62017–2019
Steele Robin JoanDirector122017–2026
Walters-Hoffert LisaOfficerChief Financial Officer82017–2023
JOHNSON SABRINA MARTUCCIDirector,Officer; Director,Officer,TenPercentOwnerChef Executive Officer; Chief Executive Officer122017–2026person page Fuzzy
Grossman Jessica D.Director112018–2026
Matz Gregory WDirector112018–2026
Blanchard Cheryl RDirector62019–2023
Fair John AOfficerChief Commercial Officer; Chief Strategy Officer62020–2024
Ononye-Onyia Sophia NnennaDirector42021–2023
Haring-Layton MarDeeOfficerChief Accounting Officer52024–2026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2026-08-20Dare Bioscience, Inc.Biotechnology$12,375,054$12,375,054121
2024-11-22Dare Bioscience, Inc.Biotechnology$15,000,000$011
2023-12-26Dare Bioscience, Inc.Biotechnology$4,160,400$1,733,50011
2019-12-06Dare Bioscience, Inc.Biotechnology$3,544,992$3,544,992282
2017-07-28Dare Bioscience, Inc.Biotechnology$20,691,388$20,691,388181
2016-10-17Cerulean Pharma Inc.Pharmaceuticals$1$111

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Plan sponsorDARE BIOSCIENCE, INC.CAForm 5500 (employee benefit plans)name and state
Federal award recipientDARE BIOSCIENCE INCCAFederal spending (USAspending)name and state
Federal award recipientDARE BIOSCIENCE, INC.CAFederal spending (USAspending)name and state
Form D issuerDare Bioscience, Inc.CAForm D private offeringsCIK (EXACT)
SEC filerDare Bioscience, Inc.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerDare Bioscience, Inc.CATrademarks (USPTO)name and state
Form 5500 plan sponsorDARE BIOSCIENCE, INC.EIN (EXACT)
Person pageEdward Graeme GarmeyPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer)
Person pageSabrina Martucci JohnsonPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, CA first:

More with this interest.

In other datasets, the same topic (Health) in CA:

Interests: Pharmaceutical Preparations · Health